Vt. lye victim gets new face at Boston hospital (Update)

February 27, 2013 in Surgery

Vt. lye victim gets new face at Boston hospital

Enlarge

In this Aug. 20, 2008 file photo, Carmen Tarleton is interviewed in her home in Thetford, Vt. Tarleton, the Vermont woman whose face was disfigured in a lye attack received a face transplant. Doctors at Boston's Brigham and Women's Hospital say 44-year-old Tarleton underwent the surgery earlier in February, 2013. A team worked 15 hours to transplant the facial skin, including the neck, nose, lips, facial muscles, arteries and nerves. (AP Photo/Toby Talbot, File)

A Vermont nurse disfigured in a 2007 lye attack has received a new face at a Boston hospital.

Carmen Blandin Tarleton's full facial transplant at Brigham & Women's Hospital included transplanting a female donor's facial skin to Tarleton's neck, nose and lips, along with facial muscles, arteries and nerves.

Vt. lye victim gets new face at Boston hospital
Enlarge

Dr. Bodhan Pomahac, at podium, with his surgical team, speaks to reporters regarding the face transplant of Carmen Blandin Tarleton, pictured left, at Brigham and Women's Hospital in Boston, Wednesday, Feb. 27, 2013. Tarleton underwent the surgery earlier this month. The 44-year-old Tarleton,of Thetford, Vt., was attacked by her former husband in 2007. He doused her with industrial strength lye. She suffered chemical burns over 80 percent of her body. The mother of two wrote a book about her experience that describes her recovery.(AP Photo/Charles Krupa)

Hospital officials say the 44-year-old Thetford, Vt., woman suffered burns on more than 80 percent of her body after her estranged husband attacked her.

Tarleton's sister said Wednesday she showed "great appreciation" for the gift she's been given.

Vt. lye victim gets new face at Boston hospital
Enlarge

In this Aug. 20, 2008 file photo, Carmen Tarleton is interviewed in her home in Thetford, Vt. Tarleton, the Vermont woman whose face was disfigured in a lye attack received a face transplant. Doctors at Boston's Brigham and Women's Hospital say 44-year-old Tarleton underwent the surgery earlier in February, 2013. A team worked 15 hours to transplant the facial skin, including the neck, nose, lips, facial muscles, arteries and nerves. (AP Photo/Toby Talbot, File)

The donor's family believes their loved one's spirit lives on in Tarleton.

Tarleton has undergone more than 50 surgeries. The latest took 15 hours and included a team of more than 30 medical professionals.

Tarleton once worked as a transplant nurse.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

PJS
Feb 28, 2013

Rank: not rated yet
brutal
Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Sexual function in older adults with thoracolumbar-pelvic instrumentation

Surgeons investigated sexual function in 62 patients, 50 years and older, who had received extensive spinal–pelvic instrumentation for spinal deformity at the University of Virginia Health Center. Based on their results, ...

Surgery created 8 hours ago | popularity not rated yet | comments 0

Challenges encountered in surgical management of spine trauma in morbidly obese patients

Physicians at Monash University and The Alfred Hospital in Melbourne, Australia describe the logistic, medical, and societal challenges faced in treating spine trauma in morbidly obese patients. Based on a case series of ...

Surgery created 8 hours ago | popularity not rated yet | comments 0

Study looks at risk factors for rupture or bleeding of arachnoid cysts in children

Arachnoid cysts are a common type of brain lesion that is usually harmless, but with a risk of rupture or bleeding. A new study identifies risk factors for rupture or bleeding in children with "incidentally" detected arachnoid ...

Surgery created 8 hours ago | popularity not rated yet | comments 0

Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...

Surgery created May 20, 2013 | popularity not rated yet | comments 0

More than one-third of Texas women still receive unnecessary breast biopsy surgery

Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast abnormality is malignant. ...

Surgery created May 17, 2013 | popularity not rated yet | comments 0


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.